Sign in

CIK 0001412486 · Non-accelerated filer<br>Smaller reporting company

Cocrystal Pharma, Inc.

Sign in to watch
Ticker
COCP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
352528215
Phone
(786) 459-1831
Business address
19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
Former names
BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
  1. 10-Q Report Quarterly Report
  2. 10-K/A Report 10-K/A
  3. 8-K Event Regulation FD disclosure
  4. D Other Notice of Sales of Unregistered Securities
  5. 4/A Open-market buy Director bought 39,216 shares at $0.51 ($20,000)
  6. 4 Open-market buy Director bought 2,941,177 shares at $0.51 ($1,500,000)
  7. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 294,118 shares at $0.51 ($150,000)
  8. 4 Open-market buy Director bought 50,000 shares at $0.51 ($25,500)
  9. 4 Open-market buy Director bought 49,020 shares at $0.51 ($25,000)
  10. 4 Open-market buy Director bought 39,216 shares at $0.51 ($20,000)
  11. 4 Open-market buy Director bought 2,941,176 shares at $0.51 ($1,500,000)
  12. 4 Open-market buy Director bought 1,235,294 shares at $0.51 ($630,000)
  13. 10-K Report Annual Report
  14. 8-K Event Regulation FD disclosure
  15. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 100,000 shares at $0.58 ($57,870)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change
  19. 10-Q Report Quarterly Report
  20. 4 Derivatives Options or other derivatives

Page 22 of 34 · 673 filings